Milan, Italy

Jerry David Ortiz Blacio

This inventor holds 1 USPTO granted patent. Top assignee: Industriale Chimica S.r.l.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerry David Ortiz Blacio. Retrieved from https://idiyas.com/inventor/jerry-david-ortiz-blacio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerry David Ortiz Blacio: Innovator in Pharmaceutical Chemistry

Introduction

Jerry David Ortiz Blacio is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug development. His work has led to advancements that could impact therapeutic applications.

Latest Patents

One of Ortiz Blacio's key patents is titled "Process for preparing (3α,5α)-3-hydroxy-3-methyl-pregnan-20-one (Ganaxolone)." This invention refers to a method for synthesizing Ganaxolone, a compound known for its potential therapeutic benefits. The patent outlines a specific process that enhances the efficiency and effectiveness of producing this important compound.

Career Highlights

Throughout his career, Ortiz Blacio has demonstrated a commitment to advancing pharmaceutical sciences. His work at Industriale Chimica S.r.l. has positioned him as a leader in the field, where he continues to explore innovative solutions for drug synthesis and development.

Collaborations

Ortiz Blacio has collaborated with esteemed colleagues, including Roberto Lenna and Andrea Fasana. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and innovations.

Conclusion

Jerry David Ortiz Blacio is a prominent figure in pharmaceutical innovation, with a focus on developing processes that improve drug synthesis. His contributions, particularly in the area of Ganaxolone, highlight his role as a key inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…